Drug Profile
Hepatitis C vaccine - JN-International Medical Corporation
Latest Information Update: 07 Sep 2023
Price :
$50
*
At a glance
- Originator JN-International Medical Corporation
- Class Hepatitis C vaccines
- Mechanism of Action Hepatitis C virus NS3 protein modulators; Hepatitis C virus NS4 protein modulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 07 Sep 2023 Discontinued - Preclinical for Hepatitis C in USA (Parenteral) (before September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Hepatitis-C in USA (Parenteral)
- 07 Jul 2016 Preclinical trials in Hepatitis C in USA (Parenteral)